Vistagen Therapeutics (VTGN) EBIT Margin (2010 - 2026)
Vistagen Therapeutics' EBIT Margin was -7925.36% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 152.88 percentage points from -7772.48% a year earlier and down 7021.03 percentage points from the prior quarter.
Vistagen Therapeutics (VTGN) EBIT Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vistagen Therapeutics' EBIT Margin was -2541.90% through Sep 30, 2026, up 6538.82 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -5683.69%, up 5833.39 percentage points from FY2025.
- EBIT Margin shows a five-year change of -4037.63 percentage points (FY2021 to FY2026).
- In earlier fiscal years, EBIT Margin was -11517.08% in FY2025 (-8413.60 pp), -3103.48% in FY2024 (+23005.77 pp), -26109.25% in FY2023 (-21800.96 pp) and -4308.30% in FY2022 (-2662.24 pp).
- The fiscal Q2 2027 figure marks the lowest quarterly EBIT Margin since fiscal Q1 2025.
- Compared with a year earlier, EBIT Margin was higher in four of the last six quarters, with an average year-over-year change of +1475.62 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was fiscal Q4 2023 (a gain of 35848.59 percentage points); the worst was fiscal Q4 2022 (a drop of 41395.55 percentage points).
- Per Business Quant data, VTGN's EBIT Margin in the three fiscal quarters before Q2 2027 was -904.34% (Q1 2027), -3595.05% (Q4 2026) and -6450.83% (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -907.40% |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 34.46% |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 24.35% |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 36.01% |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 30.74% |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 41.71% |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | -7,925.36% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -7,925.36% |
| Jun 30, 2026 | -904.34% |
| Mar 31, 2026 | -3,595.05% |
| Dec 31, 2025 | -6,450.83% |
| Sep 30, 2025 | -7,772.48% |
| Jun 30, 2025 | -6,477.05% |
| Dec 31, 2024 | -6,461.54% |
| Sep 30, 2024 | -7,774.32% |
| Jun 30, 2024 | -14,441.67% |
| Mar 31, 2024 | -6,926.22% |
| Dec 31, 2023 | -1,918.25% |
| Sep 30, 2023 | -2,260.00% |
| Jun 30, 2023 | -3,499.00% |
| Mar 31, 2023 | -6,953.98% |
| Dec 31, 2022 | -5,425.83% |
| Sep 30, 2022 | -1,958.49% |
| Jun 30, 2022 | -6,376.36% |
| Mar 31, 2022 | -42,802.56% |
| Dec 31, 2021 | -2,943.85% |
| Sep 30, 2021 | -3,575.42% |
Vistagen Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();